Asset allocators must closely monitor the progress of the coronavirus vaccine to determine whether the investment environment is “Covid-on or Covid-off”, according to T Rowe Price.
Category: Multi-asset
Schroders turns cautious towards China stocks
The firm’s China mixed-asset product has slightly trimmed down its equity allocation.
DBS PB’s barbell strategy returns 7% this year
In contrast, mixed-asset products offered by third-party fund managers have only returned around 0-2% so far this year.
UBP re-anchors portfolios
Investors should seek new ways to protect their portfolios and to generate returns, according to Union Bancaire Privée (UBP).
Asia’s HNWIs seek alts, multi-asset strategies
An online alternative investment platform in Singapore has garnered at least $100m in assets since its launch last year.
Lion Global joins income bandwagon in Singapore
Schroders, Allianz GI, Aviva Investors and Fullerton Fund Management have also launched income products in the Lion City.
JPMAM remains cautious in mixed-asset strategy
Multi-asset funds are meant to provide protection when a particular asset class tanks, but struggle to achieve their promise when normal asset class correlations break down.
Wealth managers reveal post-crisis sector picks
Private banking professionals at HSBC, Deutsche Bank, UBS, DBS and Citi reveal opportunities in the wake of economic damage wrought by the coronavirus.
Schroders reduces risk in mixed-asset fund
The multi-billion dollar fund has lifted its cash weighting, reduced equity exposure and trimmed an already low allocation to sub-investment grade credit.
Multi-asset funds attract flows in Asia
Multi-asset products have gained popularity in most markets across Asia-Pacific, according to a report this week.
